Medtech company Hologic has finalized its previously announced acquisition of Endomag, a UK-based developer of breast cancer surgery technologies, for approximately $310 million. Erik Anderson, President of Breast and Skeletal Health Solutions at Hologic noted: “We are thrilled to complete the acquisition of Endomag and are looking forward to working with our new colleagues to increase access to their innovative technologies, which…
Novocuff, a medical device company focused on improving pregnancy outcomes and reducing preterm births, has successfully closed an oversubscribed $26 million Series A funding round. The round was led by AXA IM Alts, through its Global Healthcare Private Equity Strategy, with a $14 million investment. Significant participation also came from Laerdal Million Lives Fund, along with continued support from existing and new…
French healthtech company Sonio, has introduced Soniopedia, a new cloud-based AI-powered software designed for prenatal ultrasound training. This announcement was made at the World Congress of Fetal Medicine (FMF) in Lisbon. Soniopedia aims to address the training challenges in prenatal ultrasound by simulating cases from the initial ultrasound image to the necessary genetic tests within a single cloud-based platform. Prenatal medicine is…
JOGO Health, a medtech company focused on the treatment of chronic pain and neuromuscular disorders, has closed over $5.5 million in a funding round led by Hourglass Ventures. Due to high demand from investors, JOGO Health is now extending the opportunity to the public through a Regulation CF community investment round on Wefunder. This allows retail investors to participate alongside established firms…
Papcup has introduced a non-invasive, at-home device designed to screen for cancer-causing HPV strains using regular menstrual blood. This device, developed with support from the Venture Builder Incubator (VBI) at the University of Edinburgh, aims to provide an alternative to traditional smear tests, which many women find uncomfortable and inconvenient. The device offers a highly accurate, non-invasive method for testing, allowing women…
Clarius Mobile Health has received FDA clearance for its Clarius OB AI fetal biometric measurement tool, which aims to improve access to obstetrical prenatal monitoring and care, especially in resource-limited areas. The Clarius OB AI model, now available with the Clarius C3 HD3 wireless handheld ultrasound scanner in the United States and Canada, automates fetal biometry measurements to estimate fetal age, weight,…
Femasys, a biomedical company focused on women’s health, has announced receiving European Union Medical Device Regulation (EU MDR) and CE Mark certification for four of its products. The approved products—FemaSeed, FemVue, FemCerv, and FemCath—comply with the latest EU medical device regulations, marking a significant step for Femasys as it prepares to enter the European market. This achievement follows the recent completion of…
Raydiant Oximetry, a clinical-stage medical device company focused on improving outcomes for mothers and babies during childbirth has closed an oversubscribed $7.5 million Series A3 extension round. The round was led by Cross-Border Impact Ventures (CBIV), a VC fund focused on the health of women and children worldwide. The round also included participation from RH Capital, Global Health Impact Fund, VCapital, and…
